Literature DB >> 9040199

Effective 2-wk therapy for Helicobacter pylori disease in children.

R Dohil1, D M Israel, E Hassall.   

Abstract

UNLABELLED: Successful eradication of Helicobacter pylori infection in children has required long treatment regimens that may result in noncompliance with failure to eradicate this organism. Despite full compliance with shorter therapeutic regimens, such as amoxycillin and omeprazole for 2 wk, the H. pylori eradication rate is poor in children.
OBJECTIVES: The aim of this study was to evaluate the efficacy of, and compliance with, a 2-wk treatment with metronidazole, omeprazole, and clarithromycin in eradicating H. pylori disease in children.
METHODS: Over a 15-month period, children diagnosed to be H. pylori positive by Steiner's stain of gastric antral biopsy specimens were treated with metronidazole, omeprazole, and clarithromycin. Follow-up upper GI endoscopy was performed 6-8 wk after completion of therapy.
RESULTS: Of 15 patients with H. pylori-positive antral gastritis, 11 had duodenal ulcer disease; three patients with severe abdominal pain and one with vomiting had H. pylori gastritis only. H. pylori eradication was seen in 11 of 11 (100%) patients with duodenal ulcer disease and in three of four (75%) with gastritis only; the overall success rate was 93%. Duodenal ulcer disease healed when H. pylori was eradicated in all but one patient, who at presentation had a penetrating ulcer with a duodenobiliary fistula. Fourteen of 15 patients (93%) were fully compliant, and no adverse reactions were reported.
CONCLUSIONS: Two weeks of therapy with metronidazole, omeprazole, and clarithromycin is effective H. pylori therapy in children. It is well tolerated, and full compliance can be achieved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040199

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

Review 1.  How should Helicobacter pylori infected children be managed?

Authors:  M Rowland; C Imrie; B Bourke; B Drumm
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 2.  Helicobacter pylori infection and eradication in paediatric patients.

Authors:  H M Malaty
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 3.  What do we know about benefits of H. pylori treatment in childhood?

Authors:  Mónica S Sierra; Emily V Hastings; Karen J Goodman
Journal:  Gut Microbes       Date:  2013-11-06

Review 4.  Macrolide antibiotics.

Authors:  R C Gordon
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

Review 5.  Helicobacter pylori infection in pediatric patients.

Authors:  V Tolia
Journal:  Curr Gastroenterol Rep       Date:  1999-08

6.  Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial.

Authors:  R Behrens; T Lang; K M Keller; L Bindl; M Becker; B Rodeck; P Küster; G F Wündisch; M Stolte
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

Review 7.  Pharmacokinetics of proton pump inhibitors in children.

Authors:  Catherine Litalien; Yves Théorêt; Christophe Faure
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 8.  The use of proton pump inhibitors in children: a comprehensive review.

Authors:  Troy E Gibbons; Benjamin D Gold
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 9.  Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.

Authors:  H D Langtry; M I Wilde
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

10.  A meta-analysis of the success rate of Helicobacter pylori therapy in Canada.

Authors:  Christopher Rodgers; Sander Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.